SVB FINANCIAL GROUP - Q3 2023 holdings

$53.2 Million is the total value of SVB FINANCIAL GROUP's 21 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .

 Value Shares↓ Weighting
ExitGREENLIGHT BIOSCIENCES HLDS P$0-16,950
-100.0%
-0.01%
ExitPARDES BIOSCIENCES INC$0-35,923
-100.0%
-0.12%
ExitDICE THERAPEUTICS INC$0-21,799
-100.0%
-1.91%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COINBASE GLOBAL INC4Q3 202357.5%
OKTA INC4Q3 202320.9%
ROOT INC4Q3 202314.0%
AXSOME THERAPEUTICS INC4Q3 20237.1%
CAREMAX INC4Q3 20233.0%
PLANET LABS PBC4Q3 20232.0%
MOONLAKE IMMUNOTHERAPEUTICS4Q3 20231.7%
ROVER GROUP INC4Q3 20231.2%
CULLINAN ONCOLOGY INC4Q3 20230.8%
CARIBOU BIOSCIENCES INC4Q3 20230.8%

View SVB FINANCIAL GROUP's complete holdings history.

Latest significant ownerships (13-D/G)
SVB FINANCIAL GROUP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ACHIEVE LIFE SCIENCES, INC.February 10, 20231,716,7648.8%
Root, Inc.February 10, 2023783,0128.6%
BigCommerce Holdings, Inc.February 12, 2021392,2240.6%
ISC8 INC. /DEFebruary 17, 201534,533,21311.9%

View SVB FINANCIAL GROUP's complete significant-ownership history.

Latest filings
TypeFiled
8-K2024-05-07
8-K2024-05-07
8-K2024-03-22
8-K2024-03-20
8-K2024-02-26
13F-HR2024-02-14
SC 13G/A2024-02-14
8-K2024-02-09
8-K2024-02-01
8-K2024-01-29

View SVB FINANCIAL GROUP's complete filings history.

Compare quarters

Export SVB FINANCIAL GROUP's holdings